Goldman Sachs analyst Brian Lee maintains Stem (NYSE:STEM) with a Neutral and lowers the price target from $2.5 to $2.
- Company Dashboard
- Filings
- Patents
-
Article
Goldman Sachs Maintains Neutral on Stem, Lowers Price Target to $2
Company Profile